Hints and tips:
Related Special Reports
...Rahul Titus, global head of influence at Ogilvy PR, said health influence was the “new frontier” in marketing....
...at high volumes, said Naresh Chouhan, an analyst at Intron Health....
...Another independent label said: “The new deal will badly impact our revenues.”...
...“The biggest barrier is insurance companies,” said Lawrence Honig, a neurologist at New York’s Columbia University Irving Medical Center....
...Its 13.4 per cent drop on Tuesday represented its third-biggest one-day fall of the past decade....
...J&J was valued at $367bn, as of market close in New York on Thursday....
...US-based hedge fund Shah Capital wrote to the Novavax board on Monday to push for the instalment of two new independent board directors....
...Aardvark plans to use the proceeds from its pre-IPO round to fund a late-stage clinical study into ARD-101’s efficacy on Prader-Willi patients and into patients withdrawing from GLP-1 drugs after weight...
...Additional reporting by Oliver Barnes in New York...
...Shannon Thyme Klinger, chief legal officer of Moderna, said a lack of new orders and cancellation of previous ones had resulted in more than $1bn in losses and writedowns since 2022....
...Tirzepatide is part of a new class of weight-loss drugs, known as GLP-1s, which includes Novo Nordisk’s Wegovy and Ozempic drugs, that are projected to expand to a $100bn market by the end of the decade,...
...The rise and fall of WeightWatchers Sistani describes the new WW as a judgment-free “weight health” company embracing “a full spectrum of solutions”....
...Social media platform Reddit has picked the New York Stock Exchange as the venue for its long-delayed stock market debut, according to two people familiar with the plans, a victory for the exchange in its...
...New York Community Bancorp shares shed a quarter of their value on Friday after the regional lender disclosed it had replaced its chief executive and identified “material weaknesses” in internal controls...
...Indivior aims to move primary listing from London to New York I’d never stuck with therapy....
...BlackRock’s offices have also been targeted for periodic protests by climate activists who say it has not done enough to promote decarbonisation.In 2022, the asset manager set up personal security plans...
...He was unveiled last week as the next boss of Envista, a New York-listed dental products manufacturer, with a market capitalisation of $3.4bn — about half of Smiths’ valuation....
...the pension plans of public employees — has already scored wins this proxy season at two big Wall Street banks....
...And its chief executive went further today in comments to the New York Times’s DealBook: “It’s quite clear to us that they don’t understand how consumers shop today and they don’t understand the dynamics...
...Drugmaker Indivior plans to move its primary listing from London to New York and has begun canvassing shareholder support for the switch, in the latest blow to the UK equities market....
...US health insurer Cigna has abandoned plans to merge with Humana, a blockbuster transaction that would have created a $140bn insurance giant, according to people familiar with the matter....
...The BlackRock chief also warned that the rise of defined contribution pension plans had combined with the growing strain on the social security government retirement programme to leave the US particularly...
...They hope to get the transaction agreed before the end of the year, the people said....
...“They’ve really been pushing $40 [an hour] and free health insurance.”...
International Edition